Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines
NCT03014635
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
306
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Frown Lines
Interventions
BIOLOGICAL:
Botulinum Toxins, Type A
BIOLOGICAL:
Placebos
Sponsor
Revance Therapeutics, Inc.